Chinese Academy of Sciences Jun 22 2026 Reviewed Liver transplantation remains one of the most powerful curative options for hepatocellular carcinoma (HCC) because it removes both the tumor and the diseased liver. Yet many patients are excluded because their tumors exceed the Milan criteria (MC), while others progress during long waiting periods caused by organ shortage. Locoregional treatment (LRT), including transarterial chemoembolization (TACE), radioembolization, and ablation, has improved